$4.54
5.02%
Nasdaq, Apr 21, 08:28 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$4.78
-2.03 29.81% 1M
-2.96 38.24% 6M
-2.73 36.35% YTD
-3.02 38.68% 1Y
-2.90 37.76% 3Y
-7.06 59.63% 5Y
-5.41 53.07% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
+0.06 1.27%
ISIN
CA74319B5027
Symbol
PROF
Sector

Key metrics

Market capitalization $143.59m
Enterprise Value $93.80m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.78
P/S ratio (TTM) P/S ratio 13.44
P/B ratio (TTM) P/B ratio 2.38
Revenue growth (TTM) Revenue growth 48.37%
Revenue (TTM) Revenue $10.68m
EBIT (operating result TTM) EBIT $-33.06m
Free Cash Flow (TTM) Free Cash Flow $-22.98m
Cash position $54.91m
EPS (TTM) EPS $-1.13
P/E forward negative
P/S forward 7.92
EV/Sales forward 5.18
Short interest 1.98%
Show more

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Profound Medical Corp forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Profound Medical Corp forecast:

Buy
100%

Financial data from Profound Medical Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
11 11
48% 48%
100%
- Direct Costs 3.64 3.64
29% 29%
34%
7.74 7.74
77% 77%
72%
- Selling and Administrative Expenses 23 23
32% 32%
217%
- Research and Development Expense 17 17
18% 18%
159%
-32 -32
17% 17%
-301%
- Depreciation and Amortization 1.10 1.10
4% 4%
10%
EBIT (Operating Income) EBIT -33 -33
16% 16%
-310%
Net Profit -28 -28
3% 3%
-260%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Neutral
GlobeNewsWire
6 days ago
TORONTO, April 15, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today additional details regarding its hybrid (in-person and virtual) investor event taking place on Monday, April 28, 2025...
Neutral
GlobeNewsWire
26 days ago
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
Neutral
Business Wire
about one month ago
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Profound Medical Corp. (“Profound” or the “Company”) (NASDAQ: PROF) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON PROFOUND MEDICAL CORP. (PR...
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Arun Menawat
Employees 142
Founded 2008
Website www.profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today